PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38 | -81.9% | 14,262 | -71.3% | 0.00% | -85.7% |
Q4 2022 | $210 | -99.9% | 49,760 | +144.1% | 0.03% | +55.6% |
Q2 2021 | $187,000 | +12.7% | 20,384 | +25.7% | 0.02% | 0.0% |
Q4 2020 | $166,000 | +44.3% | 16,213 | +52.4% | 0.02% | +100.0% |
Q3 2019 | $115,000 | -66.9% | 10,637 | -37.7% | 0.01% | -52.6% |
Q4 2018 | $347,000 | -47.5% | 17,065 | +209.2% | 0.02% | -42.4% |
Q3 2017 | $661,000 | – | 5,519 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |